ArticleMolecular therapy : the journal of the American Society of Gene Therapy2008
TAT opens the door.
Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson's disease models.Experimental & molecular medicine · 2018Article
- Import of TAT-Conjugated Propionyl Coenzyme A Carboxylase Using Models of Propionic Acidemia.Molecular and cellular biology · 2018Article
- Replacement of the C6ORF66 assembly factor (NDUFAF4) restores complex I activity in patient cells.Molecular medicine (Cambridge, Mass.) · 2013Article
- Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs.Cell regeneration (London, England) · 2013Article
- Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.Pharmaceutical research · 2011Review
- Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.Pediatric cardiology · 2011Article
- CPP-ZFN: a potential DNA-targeting anti-malarial drug.Malaria journal · 2010Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.